Methylprednisolone in acute spinal cord injury: Fact or fantasy?

Journal of Emergency Nursing

Volumn 27, Issue 4, 2001, Pages 401-403

  Walker, J ^a   Criddle, L M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI INFLAMMATORY AGENTS, STEROIDAL; ANTIINFLAMMATORY AGENT; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENT;

ACUTE DISEASE; ADOLESCENCE; ADOLESCENT; ADULT; ARTICLE; BOLUS INJECTION; CASE REPORT; CERVICAL SPINE; CLINICAL PROTOCOL; DRUG MEGADOSE; EMERGENCY TREATMENT; EVIDENCE BASED MEDICINE; FOOTBALL; HUMAN; INJURY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEDICAL DECISION MAKING; METHODOLOGY; NURSE; PATIENT CARE; PATIENT SELECTION; QUADRIPLEGIA; SPINAL CORD INJURY; SPINE FRACTURE; SPINE RADIOGRAPHY; STANDARD; TRAFFIC ACCIDENT; TREATMENT OUTCOME;

EID: 0035165410     PISSN: 00991767     EISSN: None     Source Type: Journal    
DOI: 10.1067/men.2001.115705     Document Type: Article

References (7)

1. Vertebral and spinal cord trauma
2. Acute spinal cord injury
3. A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury
4. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury
5. Methylprednisolone for acute spinal cord injury: An inappropriate standard of care
6. Pharmacological therapy of spinal cord injury during the acute phase
7. Nesathurai S. Steroids and spinal cord injury: Revisiting the NASCIS 2 and NASCIS 3 trials